Biomaterials and Regenerative Medicine 2026
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Biomaterials and Regenerative Medicine 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
Biomaterials and Regenerative Medicine 2026
Event type: Biomaterials, regenerative medicine, tissue engineering, medical devices, clinical research, biotech innovation, translational science, life sciences partnering
Overview: Biomaterials and Regenerative Medicine 2026 is a highly specialized life sciences event that typically attracts a concentrated mix of researchers, product developers, clinical innovators, medical device teams, biotech executives, academic labs, hospital innovation leaders, investors, and commercialization partners. This kind of event is usually valuable for buyer-list building because the audience is not broad consumer traffic; instead, it is a focused B2B and scientific ecosystem where purchasing intent is often tied to research tools, lab services, biomaterials, cell therapy, tissue scaffolds, regenerative platforms, manufacturing technologies, and clinical translation partnerships.
The strongest value of this event is not just attendance volume, but attendee quality. The people attending are often decision-makers, technical influencers, and research leaders who shape procurement, collaborations, pilot programs, vendor selection, and strategic partnerships. If your client sells into healthcare innovation, biotech, medtech, lab supplies, scientific software, CRO services, advanced materials, or research infrastructure, this event can be a very strong fit.
1️⃣ Who attends: buyers / attendees
This event is primarily attended by professionals working at the intersection of science, medicine, engineering, and commercialization. It is not a mass-market conference. It is more of a precision-targeted industry gathering where attendees are usually either directly involved in product development or influence purchasing decisions for research, clinical, and manufacturing workflows.
Main attendee groups include:
- Biomaterials scientists and regenerative medicine researchers
- Tissue engineering specialists
- Stem cell and cell therapy teams
- Medical device R&D managers
- Translational medicine directors
- Clinical research leaders
- Biotech founders and executive teams
- Academic professors, principal investigators, and lab heads
- Hospital innovation and surgical research teams
- Drug delivery and advanced therapeutics teams
- Quality, regulatory, and manufacturing professionals
- Investors, incubators, accelerators, and technology transfer teams
- Suppliers of lab instruments, biomaterials, and specialized consumables
Best buyer lens: the most valuable buyers are usually not end patients or general healthcare attendees, but rather the people responsible for research spending, vendor evaluation, product partnerships, pilot adoption, and strategic procurement.
2️⃣ Where the show is happening + attendee geographic origin
Venue/location: Please confirm the exact venue and city for Biomaterials and Regenerative Medicine 2026 if you want the research to be fully event-specific. This event name suggests a specialized scientific conference, and the geographic origin of attendees can vary depending on whether it is hosted in North America, Europe, or Asia-Pacific.
Typical attendee origin profile for this type of event:
- If held in the USA: strong national attendance from universities, hospitals, biotech hubs, medtech companies, and research institutions across the United States, with selective international participation
- If held in Europe: broad European participation from academic labs, biotech firms, and translational medicine centers, plus global exhibitors and speakers
- If held in Asia-Pacific: strong regional attendance from biomedical and regenerative medicine centers, with global partnerships and research collaboration interest
Geographic targeting advice: for attendee-list sales, geographic origin matters because scientific and healthcare events often have a core regional audience plus a secondary international delegate base. If the event is in a major biotech hub, buyer interest is usually stronger among local institutions, nearby hospitals, and regional vendors, while global companies attend for partnership-building and scouting innovation.
3️⃣ Audience reach: local / national / global
Audience reach: Usually national to global, depending on event location and speaker lineup.
This topic naturally attracts international scientists and global life sciences companies because biomaterials and regenerative medicine are globally active fields. Even when the event is hosted in one country, the audience often includes:
- International researchers
- Multinational medical device companies
- Cross-border biotech investors
- Global contract research and manufacturing organizations
- Academic collaboration partners
Best classification:
- If the conference is hosted by a local university or society chapter, it may be more regional in practice
- If it is tied to a major association or international scientific society, it becomes global
- If it is a large national conference or annual summit, it is usually national with global influence
4️⃣ Sample buyer company names + websites
Below is a sample buyer list designed for attendee-list strategy and lead targeting. These are buyer-oriented organizations that are likely to attend, exhibit, sponsor, or evaluate partnerships at a biomaterials/regenerative medicine event.
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Medtronic | medtronic.com | Director, Research & Development | Large medtech buyer with strong interest in biomaterials, implants, and regenerative innovation. |
| 2 | Johnson & Johnson MedTech | jnjmedtech.com | Manager, Scientific Partnerships | Strong fit for surgical technologies, advanced materials, and clinical innovation collaborations. |
| 3 | Abbott | abbott.com | Director, Translational Research | Broad healthcare innovation portfolio with interest in diagnostics, devices, and advanced therapies. |
| 4 | Boston Scientific | bostonscientific.com | Senior Manager, Product Development | Medical device company with relevant interest in advanced biomaterials and procedural innovation. |
| 5 | Zimmer Biomet | zimmerbiomet.com | Director, Biomaterials Strategy | Highly relevant for orthopedic materials, implants, tissue interface technologies, and regenerative solutions. |
| 6 | Stryker | stryker.com | Vice President, R&D | Strong medtech buyer with ongoing need for advanced materials, surgical systems, and biologic innovation. |
| 7 | Organogenesis | organogenesis.com | Director, Clinical Affairs | Direct regenerative medicine relevance, especially wound care, tissue repair, and cellular therapies. |
| 8 | Integra LifeSciences | integralife.com | Senior Director, Innovation | Buyer for regenerative, surgical, and implant-related technologies. |
| 9 | Cook Medical | cookmedical.com | Manager, Advanced Technologies | Medical device and specialty products company with strong innovation and materials interest. |
| 10 | 3M Health Care | 3m.com | Product Development Manager | Strong fit for medical materials, wound care, adhesives, and healthcare innovation. |
| 11 | Thermo Fisher Scientific | thermofisher.com | Director, Life Sciences Business Development | Major supplier and collaborator in research, lab infrastructure, and life sciences tools. |
| 12 | BD | bd.com | Senior Manager, Research Partnerships | Healthcare technology company with interest in diagnostics, biosciences, and clinical workflow innovation. |
| 13 | Lonza | lonza.com | Head of Cell & Gene Therapy Business Development | Excellent fit for regenerative medicine, cell processing, and manufacturing partnerships. |
| 14 | WuXi AppTec | wuxiapptec.com | Business Development Director, Biologics | Strong contract research and development fit for advanced therapeutic platforms. |
| 15 | Regenity Biosciences | regenitybiosciences.com | Director, Strategic Alliances | Directly aligned with regenerative medicine and tissue repair technologies. |
| 16 | Exactech | exac.com | VP, Product Innovation | Orthopedic and musculoskeletal technology company with biomaterials relevance. |
| 17 | Smith & Nephew | smith-nephew.com | Director, Clinical Development | Relevant for wound healing, sports medicine, and regenerative clinical applications. |
| 18 | Pfizer | pfizer.com | Director, External Innovation | Large pharma buyer with interest in translational science, research partnerships, and platform innovation. |
| 19 | Danaher | danaher.com | Group Product Manager, Life Sciences | Strong fit for life sciences tools, diagnostics, and enabling technologies used in regenerative research. |
| 20 | Amgen | amgen.com | Senior Director, Research Collaborations | Pharma-biotech innovation buyer with potential interest in cell therapy, biologics, and advanced research. |
Top 5 best samples to send first: Medtronic, Johnson & Johnson MedTech, Zimmer Biomet, Organogenesis, and Thermo Fisher Scientific. These give you a balanced buyer set across medtech, regenerative medicine, and research infrastructure.
5️⃣ Job profiles, industries & event type
Best job profiles to target:
- Director, R&D
- Head of Biomaterials
- Director, Translational Research
- Senior Scientist / Principal Scientist
- VP, Product Development
- Director, Clinical Affairs
- Director, Scientific Affairs
- Business Development Director
- Manager, External Innovation
- Director, Technology Transfer
- Head of Cell & Gene Therapy
- Medical Device Innovation Lead
- Regenerative Medicine Program Manager
- Research Partnerships Manager
- Lab Director / Core Facility Director
- Director, Manufacturing Science & Technology
- Quality and Regulatory Affairs Manager
- Chief Scientific Officer
- VP, Strategic Alliances
- Clinical Research Director
Best industries to use from your industry list:
- Biotechnology
- Pharmaceuticals
- Medical Devices
- Research
- Hospital & Health Care
- Higher Education
- Health, Wellness & Fitness
- Information Services
- Management Consulting
- Nanotechnology
- Mechanical or Industrial Engineering
- Electrical/Electronic Manufacturing
- Computer Software
- Medical Practice
- Biotechnology suppliers and life sciences tools companies
Event type summary: This is best categorized as a high-value scientific and commercial conference with strong B2B potential, especially for research services, advanced materials, medtech, life sciences tools, lab equipment, and innovation partnerships.
6️⃣ Estimated attendance / expected footfall
Without the official event page and venue details, the safest way to estimate is by positioning the event in one of three attendance bands:
- Small specialized symposium: 150–400 attendees
- Mid-sized scientific conference: 400–1,200 attendees
- Large annual industry summit: 1,200–3,000+ attendees
Best assumption: Biomaterials and regenerative medicine events usually perform best as a medium-to-high-value niche conference. Even if the total footfall is not massive, the buyer concentration tends to be excellent because of the quality of the audience.
What matters most for lead value:
- Number of exhibitors and sponsors
- Presence of academic and industry keynote speakers
- Scientific sessions vs. commercialization sessions
- Whether there is an expo floor, partnering area, or startup showcase
- Whether the event includes hospitals, medtech, and investment participation
7️⃣ Key focus areas & buyer engagement
Common focus areas for this event category:
- Biomaterials design and characterization
- Regenerative medicine and tissue repair
- Stem cell technologies
- Cell and gene therapy enabling platforms
- 3D bioprinting and scaffold development
- Implants and biologically active materials
- Clinical translation and commercialization
- Wound healing and tissue engineering
- Advanced therapeutics manufacturing
- Medical device integration with biologic systems
- Lab automation and analytical instrumentation
- Regulatory pathway and quality systems
- Research partnerships, licensing, and tech transfer
Buyer engagement strategy: The right way to pitch this event is through use-case value, not generic attendance. Examples:
- “Reach decision-makers in biomaterials R&D, regenerative medicine, and translational science.”
- “Connect with medical device innovation teams, research directors, and clinical partnership leaders.”
- “Target scientists and commercial teams evaluating new platforms, materials, and lab solutions.”
Because this audience is technical, they respond better to specific problem-solving language such as “scaffold development,” “tissue repair,” “cell therapy workflow,” “clinical translation,” “advanced materials,” and “regulatory-ready innovation.”
8️⃣ Client-product fit note
To identify the best buyers for this event, I need your client website first. That will let me understand what your client actually sells and whether they should target research buyers, medtech companies, clinical teams, lab procurement teams, or innovation partnerships.
Why this matters:
- If your client sells lab consumables, the best buyers are research labs, biotech firms, and university core facilities
- If your client sells software, the best buyers are research directors, bioinformatics teams, and translational innovation leaders
- If your client sells equipment, the best buyers are lab managers, manufacturing heads, and procurement teams
- If your client sells consulting or CRO services, the best buyers are biotech founders, R&D leaders, and clinical development teams
- If your client sells funding, IP, or partnership services, the best buyers are technology transfer and business development leaders
So please share the client website before finalizing the exact buyer list. I can then refine the sample accounts and titles based on product-market fit, buying intent, and event relevance.
9️⃣ Suggested industries based on your industry list
For this event, the most relevant industry filters are:
- Biotechnology
- Pharmaceuticals
- Medical Devices
- Research
- Hospital & Health Care
- Higher Education
- Health, Wellness & Fitness
- Nanotechnology
- Mechanical or Industrial Engineering
- Electrical/Electronic Manufacturing
- Computer Software
- Information Services
- Management Consulting
- Professional Training & Coaching
- Biotech-related startup and innovation companies
Final recommendation
Buyer-list value: High, if the event includes industry participation, exhibits, and partnering sessions.
Best audience segments to collect:
- R&D and scientific leadership
- Translational and clinical development teams
- Biotech and medtech business development leaders
- Academic principal investigators and lab directors
- Innovation and technology transfer teams
- Medical device and life sciences suppliers
- Investors and strategic partners
Quality rating for attendee-list sales: 8.5/10
This is a strong event for targeted B2B data because the audience is highly specialized and often linked to product adoption, research procurement, collaboration decisions, and commercialization opportunities. The event becomes even more valuable if the attendee list includes exhibitors, sponsors, academic leaders, and company representatives rather than only researchers.
Next step: Share your client website, and I will review it and return the best buyer companies, best job titles, and best industry filters tailored specifically to that client.
Data sheet
| Event Name | Biomaterials and Regenerative Medicine 2026 |
| Event Date | 15 June 2026 - 17 June 2026 |
| Event Status | Completed |
| Venue | Rome |
| City | Rome |
| State / Region | Rome |
| Country | Italy |
| Organizer | Not publicly confirmed from the provided event brief. |
| Official Event Website | Official event website not verified from the provided details. |
| Event Type | Scientific conference / B2B partnering event focused on biomaterials, regenerative medicine, tissue engineering, medical devices, clinical research, and biotech innovation |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; IT & Technology |
| Audience Reach | Likely international scientific and industry audience, with strong European relevance |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low for numeric attendance; moderate for audience profile based on event theme and standard participant mix for this conference type |
| Main Purpose of Event | To connect biomaterials researchers, regenerative medicine innovators, translational scientists, medtech and biotech stakeholders, and commercialization partners for knowledge exchange, sourcing, collaboration, and clinical translation opportunities |
Biomaterials and Regenerative Medicine 2026 appears to be a specialized life sciences conference centered on advanced biomaterials, tissue engineering, regenerative therapies, translational science, medical device development, and clinically relevant biotech innovation. Based on the subject matter provided, the event is best understood as a focused scientific and commercial meeting rather than a broad public expo, making it potentially useful for organizations selling into research, clinical development, innovation infrastructure, and specialized medtech or biotech workflows.
This type of event typically matters because attendee quality often outweighs scale. Relevant participants commonly include academic principal investigators, R&D teams, hospital innovation leaders, medical device developers, biotech executives, lab procurement stakeholders, commercialization partners, and investors. For lead generation, the strongest opportunity is usually targeted account identification, partnership outreach, and high-value scientific buyer profiling rather than mass-footfall consumer marketing.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Academic research leaders | Universities, biomedical institutes, tissue engineering labs | Influence specification, protocol selection, research platform adoption, grant-based purchasing | High relevance for lab supplies, biomaterials, software, instrumentation, assay platforms, CRO support |
| Clinical innovators and translational medicine teams | Hospitals, university medical centers, clinical research networks | Evaluate clinical applicability, pilot partnerships, translational workflow needs | Strong fit for clinical services, validation support, device platforms, data systems, regulatory consulting |
| Biotech R&D and platform development teams | Regenerative medicine companies, cell therapy firms, biomaterials developers | Direct buyers or evaluators for materials, process tools, analytics, manufacturing inputs | Very high relevance for technology vendors, formulation providers, testing labs, manufacturing partners |
| Medical device product development teams | Implant developers, scaffold technology firms, medtech manufacturers | Assess component materials, prototype support, quality systems, translational feasibility | High relevance for advanced materials suppliers, regulatory specialists, engineering service firms |
| Procurement and lab operations teams | Research institutions, biotech firms, hospital research departments | Control approved vendors, purchasing processes, supplier onboarding | Important for converting technical interest into contracts and repeat supply relationships |
| Commercialization and business development leaders | Biotech, medtech, technology transfer offices, innovation accelerators | Shape licensing, distribution, co-development, strategic partnerships | Useful for partnership-led selling, channel development, and pilot program expansion |
| Regulatory, quality, and clinical affairs specialists | Medical device and biotech companies, CROs | Influence validation, compliance, trial readiness, documentation workflows | Relevant for software, consulting, testing, manufacturing quality, and data traceability solutions |
| Investors and innovation partners | Life sciences investors, venture funds, incubators, strategic corporate investors | Indirect buying influence via portfolio support, partnerships, commercialization acceleration | Useful for channel access, partnership mapping, and market intelligence |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Rome | Local university, hospital, life sciences, and research attendees | Medium | Strong local relevance for medical research institutions, hospitals, and public-sector scientific bodies |
| Lazio / Central Italy | Regional academic, clinical, and biotech professionals | Medium | Likely draw for nearby research clusters and clinical centers |
| Northern Italy biotech hubs | Milan, Turin, Bologna, and other innovation centers | High | Likely source of medtech, biotech, and advanced manufacturing stakeholders |
| Italy national reach | Universities, hospitals, startups, device companies, CROs, and research platforms | High | Subject matter is nationally relevant across research and translational medicine communities |
| Europe | EU research consortia, biotech firms, medtech developers, academic labs | High | Regenerative medicine and biomaterials are strongly collaborative across European research networks |
| International | Selective participation from North America, UK, Asia-Pacific, and Middle East research and industry groups | Medium | International participation is likely for a specialized scientific field, but not publicly confirmed for this edition |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification with strong European concentration | The conference topic is internationally relevant and scientifically specialized, which typically attracts cross-border research and innovation participation. However, verified attendee-origin data for the 2026 edition was not publicly confirmed from the provided materials. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Sapienza University of Rome | Academic research institution | Relevant for biomaterials, tissue engineering, translational biomedical research, and lab procurement | uniroma1.it | Professor, Principal Investigator, Lab Manager, Research Director, Procurement Officer | Strong Market Fit, Attendance Not Confirmed |
| University of Rome Tor Vergata | Academic research institution | Likely relevance in biomedical materials, regenerative biology, and university-hospital collaboration | uniroma2.it | Department Head, PI, Research Scientist, Innovation Manager | Strong Market Fit, Attendance Not Confirmed |
| Università Cattolica del Sacro Cuore | Academic / clinical research institution | Relevant for translational research, biomaterials evaluation, and hospital-linked innovation activity | unicatt.it | Clinical Research Director, PI, Biomedical Engineering Lead | Strong Market Fit, Attendance Not Confirmed |
| Fondazione Policlinico Universitario A. Gemelli IRCCS | Hospital / clinical innovation organization | Relevant for clinical translation, trial collaboration, regenerative treatment evaluation | gemelli.it | Clinical Innovation Lead, Department Director, Research Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
| Bambino Gesù Children's Hospital | Hospital / pediatric research organization | Potential relevance for regenerative medicine, translational pediatrics, and advanced biomedical research | ospedalebambinogesu.it | Research Director, Clinical Program Manager, Lab Operations Manager | Strong Market Fit, Attendance Not Confirmed |
| Istituto Superiore di Sanità | Government scientific body | Relevant for public health research, scientific collaboration, and policy-linked innovation activity | iss.it | Research Program Lead, Scientific Director, Procurement Specialist | Strong Market Fit, Attendance Not Confirmed |
| Humanitas Research Hospital | Hospital / biomedical research institution | Relevant for translational medicine, regenerative science, and innovation partnerships | humanitas.it | Clinical Research Director, Lab Director, Innovation Partnerships Manager | Strong Market Fit, Attendance Not Confirmed |
| IRCCS San Raffaele | Hospital / research institution | Strong relevance for advanced therapies, clinical translation, and biomaterials-related innovation | hsr.it | Medical Director, Translational Research Lead, Clinical Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
| Chiesi Group | Pharma / advanced therapies stakeholder | Relevant for translational science partnerships, drug-device interactions, and innovation scouting | chiesi.com | R&D Director, External Innovation Manager, Scientific Partnerships Lead | Strong Market Fit, Attendance Not Confirmed |
| Menarini Group | Pharma / life sciences organization | Potential fit for innovation sourcing, translational partnerships, and biomedical collaboration | menarini.com | Scientific Affairs Director, Innovation Lead, Procurement Category Manager | Strong Market Fit, Attendance Not Confirmed |
| Philips | Medtech / healthcare technology company | Relevant where imaging, digital health, and clinical innovation overlap with regenerative workflows | philips.com | Healthcare Innovation Director, Clinical Partnerships Lead, R&D Program Manager | Strong Market Fit, Attendance Not Confirmed |
| Johnson & Johnson MedTech | Medical device manufacturer | Relevant for advanced materials, implant technologies, and translational product development | jnjmedtech.com | R&D Director, Biomaterials Scientist, Product Development Manager | Strong Market Fit, Attendance Not Confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Director of R&D | Research & Development | Director | Controls platform evaluation, innovation partnerships, and scientific buying priorities |
| 2 | Principal Investigator | Research | Senior | Key scientific influencer for materials, instruments, software, and service adoption |
| 3 | Head of Translational Medicine | Clinical / Translational Research | Head / Director | Drives movement from research to clinical application and partnership selection |
| 4 | Lab Manager | Laboratory Operations | Manager | Often manages day-to-day vendor use, equipment needs, and recurring consumable purchasing |
| 5 | Procurement Manager | Procurement / Sourcing | Manager | Critical for vendor onboarding, pricing, compliance, and purchase authorization |
| 6 | Clinical Research Director | Clinical Research | Director | Important for trial support services, translational validation, and regulated workflow purchases |
| 7 | Product Development Manager | Product / Engineering | Manager | Relevant in device design, component selection, and biomaterial platform evaluation |
| 8 | Business Development Director | Business Development / Partnerships | Director | Useful for strategic alliances, co-development deals, and commercial outreach |
| 9 | Quality / Regulatory Affairs Manager | Quality / Regulatory | Manager | Influences compliant solution adoption and supplier qualification |
| 10 | Innovation Partnerships Manager | Innovation / External Collaboration | Manager | Valuable for pilot projects, consortia, and commercial-scientific collaborations |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Biotechnology | Core fit for regenerative medicine and translational platform development | Cell therapy, tissue engineering, advanced research workflows |
| 2 | Medical Devices | Biomaterials and scaffold innovations often connect directly to medtech product development | Implants, device materials, product validation |
| 3 | Pharmaceuticals | Relevant for translational science, combination products, and therapy innovation | Scientific alliances and clinical development support |
| 4 | Hospital & Health Care | Clinical centers and research hospitals are major end users and evaluation sites | Pilot studies, translational projects, procurement |
| 5 | Research | High relevance for institutes, labs, and scientific centers | Instrumentation, software, materials, and services |
| 6 | Higher Education | Universities and academic labs are likely major participants | Grant-funded research purchasing and collaboration |
| 7 | Information Technology & Services | Useful where bioinformatics, lab software, AI, or data platforms are relevant | Scientific data systems and digital research infrastructure |
| 8 | Computer Software | Relevant for modeling, imaging, design, and lab workflow platforms | R&D support, data capture, collaboration tools |
| 9 | Mechanical or Industrial Engineering | Applicable for advanced manufacturing, biomaterial processing, and device engineering | Prototype development and production partnerships |
| 10 | Government Administration | Relevant for public research institutes, healthcare systems, and national science bodies | Scientific procurement and public innovation programs |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer. | Unconfirmed | No verified organizer attendance data available from the provided brief | Numeric estimate intentionally not invented |
| Exhibitor count | Not publicly confirmed | Unconfirmed | No official exhibitor directory verified | May be conference-led rather than expo-led |
| Buyer count | Not publicly confirmed | Unconfirmed | No official attendee segmentation report verified | Buyer quality likely stronger than buyer volume |
| Speaker count | Not publicly confirmed | Unconfirmed | Agenda or speaker page not verified | Likely multi-speaker scientific format |
| Sponsor count | Not publicly confirmed | Unconfirmed | No official sponsor page verified | Potentially relevant for account-based prospecting if source becomes available |
| Historical attendance | Historical data not verified | Unavailable | Prior-year official attendance source not available in the supplied details | No historical numeric benchmark included |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Biomaterials research | Novel materials, characterization tools, reproducibility support | Scientific demos, validation studies, sample programs | Advanced materials, testing services, instrumentation |
| Regenerative medicine | Platforms supporting tissue repair, engineered constructs, translational workflows | Co-development discussions and pilot evaluations | Cell therapy support tools, scaffold systems, clinical translation services |
| Tissue engineering | Scaffolds, bioreactors, manufacturing methods, imaging and analysis | Technical workshops, product trials, method comparison | Engineering services, bioprocess equipment, software |
| Medical devices | Biocompatible materials, prototype support, regulatory readiness | Product development meetings and supplier qualification | Materials, design engineering, validation and quality support |
| Clinical research | Trial design support, translational evidence, clinical workflows | Hospital and CRO partnership outreach | Clinical services, data capture systems, protocol support |
| Biotech innovation | Platform scalability, external innovation, R&D acceleration | Strategic partnerships and business development meetings | R&D outsourcing, technology partnerships, specialized supply |
| Scientific software and data | Analysis, traceability, collaboration, imaging and modeling tools | Use-case driven demos for research and clinical teams | LIMS, analytics software, simulation, AI-enabled workflow tools |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | The event theme points to a concentrated audience of scientific, clinical, and innovation stakeholders rather than general visitors. |
| Decision-maker availability | High | Likely access to PIs, R&D leaders, partnership managers, and institutional decision influencers. |
| Data collection potential | Medium | Strong qualitative lead value, but attendee count and public participant data were not verified from official sources. |
| Apollo targeting potential | Very High | Clear buyer-industry mapping exists across biotech, medtech, hospitals, universities, and research institutions. |
| Geographic targeting potential | High | Rome, Italy, and Europe provide efficient account clustering for scientific outreach. |
| Best outreach approach | High-value account-based outreach | Use technical messaging, collaboration angles, and product-validation language rather than broad sales messaging. |
| Overall lead quality | High | Particularly strong for specialized B2B, scientific, medtech, and biotech offerings. |
| Best use case | Strategic buyer-list building and partnership targeting | Best suited for quality-first lead generation, account mapping, and scientific-commercial outreach. |
| Limitations / risks | Medium | Publicly verified attendee and organizer data were not available from the supplied event details, so list-building should be validated against official records if required. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Biotechnology; Medical Devices; Pharmaceuticals; Hospital & Health Care; Research; Higher Education; Information Technology & Services; Computer Software; Mechanical or Industrial Engineering; Government Administration | Covers the most relevant scientific, clinical, and translational buyer segments |
| Departments | Research, Engineering, Clinical, Procurement, Operations, Business Development, Partnerships, Quality, Regulatory | Aligns outreach to both technical and commercial decision pathways |
| Seniority | Manager, Director, Head, VP, CXO, Owner, Partner, Professor-level equivalents where available | Targets influencers and budget-controlling roles |
| Job titles | Director of R&D, Principal Investigator, Lab Manager, Head of Translational Medicine, Clinical Research Director, Product Development Manager, Procurement Manager, Quality Manager, Regulatory Affairs Manager, Business Development Director, Innovation Partnerships Manager | Focuses on the strongest functional entry points |
| Geography | Italy first; then broader Europe including UK, Germany, France, Switzerland, Netherlands, Spain, Belgium, Sweden | Builds around the event location and likely scientific travel corridors |
| Employee size | 11-50; 51-200; 201-500; 501-1000; 1001-5000; 5001+ | Captures startups, scale-ups, hospitals, universities, and established medtech/pharma groups |
| Keywords | biomaterials, regenerative medicine, tissue engineering, scaffold, cell therapy, translational medicine, medical device, biocompatibility, clinical research, advanced therapies, biomaterial characterization | Improves topical accuracy within broad life sciences accounts |
| Technologies, if relevant | LIMS, imaging software, data analysis platforms, CAD/CAE, bioprocess systems, quality management software | Useful when selling software, lab systems, or engineering tools |
| Revenue range, if relevant | Use broad range filters; refine based on client price point | Supports segmentation between academic buyers, SMEs, and enterprise accounts |
| Company type | Private, Public, Nonprofit, Educational, Government-linked, Hospital systems | Matches the mixed institutional structure common in this field |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| User-provided event brief | Provided input | Event name, city, region, country, venue reference, and event dates; thematic description used for audience profiling | Moderate |
| Official organizer / event website | Primary source expected but not verified | Organizer, venue details, attendance, exhibitor, sponsor, and speaker confirmation were not publicly verified from the supplied materials | Unavailable |
| Institution and company websites listed in sample buyer table | Organization websites | Existence and market relevance of prospecting targets only; not attendance confirmation | High for organization existence; not valid for event participation status |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Biomaterials and Regenerative Medicine 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.